Brief: Sequent Scientific's Mangalore facility gets establishment inspection report from USFDA
09/11/2015 06:24
Nov 9 (Reuters) - SeQuent Scientific Ltd SEQU.BO : * Sequent receives establishment inspection report from US FDA for its api drug manufacturing facility at Mangalore * Facility continues status of being acceptable by USFDA * Source text: http://bit.ly/1L5IQ7K * Further company coverage SEQU.BO ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on Viyash Scientific
See all newsBrief: Viyash Scientific Partners With Boehringer Ingelheim In India
Brief: Sequent Scientific Dec-qtr consol loss narrows
Brief: Sequent Scientific unit to acquire Topkim, Turkey
Brief: Sequent Scientific's Mangalore facility gets establishment inspection report from USFDA
Brief: Sequent Scientific approves sub-division of equity shares